Bay Area???s Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-dynavax.jpg" NAME"Bay Areas Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff" ALT"Bay Areas Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff"March 13, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingBay Area???s Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff

Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down3.jpg" NAME"Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg" ALT"Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits…

Continue ReadingShakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg

FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials" ALT"FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials"March 13, 2017By Alex Keown, BioSpace.com Breaking News Staff... Source: BioSpace

Continue ReadingFDA Demands Karyopharm Stop Enrollment of All Selinexor Trials